CBIO Catalyst Biosciences Inc

Catalyst Biosciences Inc is a clinical-stage biopharmaceutical company. The Company is engaged in creating and developing novel medicines to address serious medical conditions.

As of 09/30/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  04/12/2006
Outstanding shares:  31,477,053
Average volume:  1,269,690
Market cap:   $16,172,910
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -0.20
PB ratio:   0.59
PS ratio:   2.43
Return on equity:   -295.49%
Net income %:   -1,200.77%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy